Document Classification

Section Type: RESULTS

Text: However, there was a significant interaction between bleeding and potency of antiplatelet therapy for all-cause (P =. 002), cardiovascular (P =. 02), and cancer mortality (P =. 03) ; in subjects on aspirin alone, moderate/severe bleeding was associated with all-cause (HR 5. 27, 95 % CI 3. 56-7. 80), cardiovascular (HR 4. 33, 95 % CI 2. 55-7. 37), and cancer mortality (HR 9. 01, 95 % CI 4. 41-18. 43), but not in subjects on DAPT (all-cause : HR 1. 48, 95 % CI 0. 93-2. 34 ; cardiovascular : HR 1. 04, 95 % CI 0. 58-1. 86 ; and cancer mortality : HR 1. 79, 95 % CI 0. 56-5. 74).